| 骨髓增生异常综合征相关疾病特征及预后评估研究进展 |
| |
| 引用本文： | 杨洁,陈宝安.骨髓增生异常综合征相关疾病特征及预后评估研究进展[J].白血病．淋巴瘤,2018,27(3):143-144,153. |
| |
| 作者姓名： | 杨洁 陈宝安 |
| |
| 作者单位： | 东南大学附属中大医院血液科 江苏省医学重点学科 东南大学MDS研究所, 南京,210009;东南大学附属中大医院血液科 江苏省医学重点学科 东南大学MDS研究所, 南京,210009 |
| |
| 基金项目： | 江苏省医学重点学科(2010-2020)，江苏省科技厅医学重点项目，Key Medical Discipline of Jiangsu Province(2010-2020)，Key Medical Project of Science and Technology Office of Jiangsu Province |
| |
| 摘 要： | 骨髓增生异常综合征(MDS)是一组起源于造血干/祖细胞的获得性克隆性疾病,以无效造血和易转化为急性白血病为特点.第59届美国血液学会(ASH)年会就MDS的发病机制、治疗靶点、新型药物及临床研究进行了一系列详尽的报道,文章结合会议报道对MDS相关疾病特征及预后评估研究进展进行介绍.
|
| 关 键 词： | 骨髓增生异常综合征 特征 预后评估 |
Progress of related diseases features and prognostic evaluation of myelodysplastic syndromes |
| |
| Yang Jie,Chen Baoan.Progress of related diseases features and prognostic evaluation of myelodysplastic syndromes[J].Journal of Leukemia & Lymphoma,2018,27(3):143-144,153. |
| |
| Authors: | Yang Jie Chen Baoan |
| |
| Abstract: | Myelodysplastic syndromes (MDS) characterized by the presence of ineffective hematopoiesis and an increased risk of transformation to acute myeloid leukemia (AML), is a group of clonal disorders deriving from the hematopoietic stem/progenitor cells. The 59th American Society of Hematology (ASH) Annual Meeting introduced detailed reports on disease genes, the molecular mechanism, therapeutic targets, new drugs and clinical research of MDS. Combined with reports in the 59th ASH Annual Meeting, this article summarizes the latest progress of the related diseases features and prognostic evaluation of MDS. |
| |
| Keywords: | |
| 本文献已被 万方数据 等数据库收录！ |
|
